129 related articles for article (PubMed ID: 21802380)
21. Novel FAM134B mutations and their clinicopathological significance in colorectal cancer.
Islam F; Gopalan V; Wahab R; Lee KT; Haque MH; Mamoori A; Lu CT; Smith RA; Lam AK
Hum Genet; 2017 Mar; 136(3):321-337. PubMed ID: 28144752
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
24. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression.
Zhang C; Fang Z; Xiong Y; Li J; Liu L; Li M; Zhang W; Wan J
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):834-8. PubMed ID: 20929925
[TBL] [Abstract][Full Text] [Related]
25. p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer.
Wen S; Gao J; Zhang L; Zhou H; Fang D; Feng S
Oncotarget; 2016 Nov; 7(46):75981-75995. PubMed ID: 27732955
[TBL] [Abstract][Full Text] [Related]
26. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.
Kontos CK; Papadopoulos IN; Fragoulis EG; Scorilas A
Br J Cancer; 2010 Apr; 102(9):1384-90. PubMed ID: 20424616
[TBL] [Abstract][Full Text] [Related]
27. Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.
Wong HS; Chang WC
Oncotarget; 2015 Dec; 6(39):42169-82. PubMed ID: 26543234
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer.
Shida D; Inoue S; Yoshida Y; Kodaka A; Tsuji T; Tsuiji M
World J Gastroenterol; 2016 Feb; 22(8):2503-11. PubMed ID: 26937138
[TBL] [Abstract][Full Text] [Related]
29. Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers.
Yu J; Miller R; Zhang W; Sharma M; Holtschlag V; Watson MA; McLeod HL
Pharmacogenomics; 2008 Oct; 9(10):1459-66. PubMed ID: 18855534
[TBL] [Abstract][Full Text] [Related]
30. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
31. GAEC1 mutations and copy number aberration is associated with biological aggressiveness of colorectal cancer.
Lee KT; Gopalan V; Islam F; Wahab R; Mamoori A; Lu CT; Smith RA; Lam AK
Eur J Cell Biol; 2018 Apr; 97(3):230-241. PubMed ID: 29555101
[TBL] [Abstract][Full Text] [Related]
32. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
34. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
Gassler N; Herr I; Schneider A; Penzel R; Langbein L; Schirmacher P; Kopitz J
J Pathol; 2005 Nov; 207(3):295-300. PubMed ID: 16110457
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Riboflavin Transporters in Human Colorectal Cancer.
Tutino V; Defrancesco ML; Tolomeo M; DE Nunzio V; Lorusso D; Paleni D; Caruso MG; Notarnicola M; Barile M
Anticancer Res; 2018 May; 38(5):2659-2667. PubMed ID: 29715086
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
[TBL] [Abstract][Full Text] [Related]
37. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
Islam F; Gopalan V; Vider J; Wahab R; Ebrahimi F; Lu CT; Kasem K; Lam AKY
Exp Cell Res; 2017 Aug; 357(2):260-270. PubMed ID: 28549913
[TBL] [Abstract][Full Text] [Related]
39. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features.
Lam AK; Ong K; Ho YH
Int J Colorectal Dis; 2008 Jun; 23(6):587-94. PubMed ID: 18322660
[TBL] [Abstract][Full Text] [Related]
40. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
